Cliawaived Inc - San Diego, California 92121

Cliawaived Inc is categorized under in San Diego, CA .

Business Name: Cliawaived Inc
Contact Person: Tim Drapeau
Address: 11578 Sorrento Valley Road, San Diego, California 92121
Phone Number: (858) 481-5031
Website Address: drugtesting-kits.com
Annual Revenue (USD): Unknown
Location Type: Branch
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category:
SIC Code: 5047
NAICS Code: 423450
Share This Business:
Related Businesses: Integra - San Diego, CA 92121
Dynamed Health Care Systems Inc - San Diego, CA 92121
Coast Reproductive - San Diego, CA 92121
Acon Laboratories Inc - San Diego, CA 92121
Avail Westcoast Div - San Diego, CA 92121
Access Scientific Inc - San Diego, CA 92121
Armstrong Medical Industries - San Diego, CA 92121
Nuvasive Inc - San Diego, CA 92121
Kinetic Surgical - San Diego, CA 92121
Academy Medical Equipment - San Diego, CA 92121
Ros LLC - San Diego, CA 92121
D N A Dynamics - San Diego, CA 92121
Oberlin Medical Supply & Service Corp - San Diego, CA 92121
Metra Biosystems Inc - San Diego, CA 92121
Olympus America Inc - San Diego, CA 92121
Advanced Neurometrics Inc - San Diego, CA 92121
Clini Comp International - San Diego, CA 92121
Intellidot Corporation - San Diego, CA 92121
Cholestech Corp - San Diego, CA 92121
Biosite Inc - San Diego, CA 92121

The company Cliawaived Inc provides B2B services in the form of from its branch in California. 1 to 4 employees work for Cliawaived Inc, and the business now earns Unknown per annum.

Cliawaived Inc was launched in 0 and is classified under SIC code and category 5047 , and NAICS number and grouping 423450 . To contact Cliawaived Inc, please call Tim Drapeau with the phone number (858) 481-5031 or visit its branch at 11578 Sorrento Valley Road in San Diego, California 92121.

The location of the branch can also be found using the coordinates 32.911349,-117.231294. Read more details about this business on the webpage drugtesting-kits.com or follow the company’s social media accounts, on Twitter and on Facebook.